BREAKINGMulti-Source
Hims & Hers is a brave bet on solving the disruptor’s dilemma
Financial Times|2/15/2026
H
Hims
16 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
8
Activity (Last 30 Days)
1
2
2
2
1
2026-02-052026-02-15
Top Publishers
Reuters3 stories
CNBC2 stories
Financial Times2 stories
Stat News1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
Stocks making the biggest moves midday: Oracle, Cleveland-Cliffs, Nexstar, Workday, Hims & Hers
CNBC|2/9/2026
UNVERIFIEDSingle Source
Stocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and more
CNBC|2/9/2026
UNVERIFIEDSingle Source
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Financial Times|2/7/2026
UNVERIFIEDSingle Source
HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy - statnews.com
Stat News|2/7/2026
UNVERIFIEDSingle Source
US signals crackdown on compounded weight-loss drugs; Hims shares tumble
Reuters|2/6/2026
UNVERIFIEDSingle Source
Hims & Hers' $49 weight-loss pill jolts everyone, except its stock
Reuters|2/6/2026
UNVERIFIEDSingle Source
Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly
Reuters|2/5/2026